Conference Call with Biocon Ltd. Management and Analysts on Q2FY24 Performance and Outlook. Listen to the full earnings transcript. Management in attendance: Kiran Mazumdar Shaw and senior team
Conference Call with Biocon Management and Analysts on Q1FY24 Performance and Outlook. Listen to the full earnings transcript. Management in attendance: Kiran Mazumdar Shaw and Senior Team
This is further to our earlier letter dated May 24, 2023 regarding presentation and video recording of Q4 and full year FY23 Earnings Call held on May 24, 2023, please find enclosed herewith the transcript of the Earnings Call. The same is also available on the website of the Company at https://www.biocon.com/investor-relations/financial-information/earning-call-transcripts/
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), please find enclosed the presentation on Q4 and full year FY23 Earnings Call conducted today i.e. on May 24, 2023. The same is also available on the website of the Company at www.biocon.com. Further, the Video Recording w.r.t. the Earnings Call is also available on the website of the Company at https://www.biocon.com/news-biocon/video-gallery-biocon/quarterly-statements-biocon/#1653297216088-5a4e9281-2d49.
Conference Call with Biocon Management and Analysts on Q4FY23 Performance and Outlook. Listen to the full earnings transcript. Management in attendance: Kiran Mazumdar Shaw and Senior Team
